Annual report

Period2021-01-01 → 2021-12-31

Filed2023-03-03

StandardJapan GAAP

ConsolidatedYes

Data checks24 of 24 passed

Amends S100NPBX. Amended by S100QC29 (2023-03-03).

Key figures · 148

Metric	Value	Period	Scope	Source row
Revenue	¥78.6bn	2021-01-01 → 2021-12-31	Cons.	Net sales
Revenue	¥77.7bn	2020-01-01 → 2020-12-31	Cons.	Net sales
Revenue	¥75.4bn	2019-01-01 → 2019-12-31^d	Cons.	Net sales (5-year summary)
Revenue	¥77.2bn	2018-01-01 → 2018-12-31^d	Cons.	Net sales (5-year summary)
Revenue	¥78.7bn	2017-01-01 → 2017-12-31^d	Cons.	Net sales (5-year summary)
Operating income	¥1.2bn	2021-01-01 → 2021-12-31	Cons.	Operating income
Operating income	¥2.2bn	2020-01-01 → 2020-12-31	Cons.	Operating income
Ordinary income	¥1.3bn	2021-01-01 → 2021-12-31	Cons.	Ordinary income
Ordinary income	¥2.2bn	2020-01-01 → 2020-12-31	Cons.	Ordinary income
Ordinary income	¥1.7bn	2019-01-01 → 2019-12-31^d	Cons.	Ordinary income loss (5-year summary)
Ordinary income	¥1.6bn	2018-01-01 → 2018-12-31^d	Cons.	Ordinary income loss (5-year summary)
Ordinary income	¥1.9bn	2017-01-01 → 2017-12-31^d	Cons.	Ordinary income loss (5-year summary)
Profit before tax	¥464m	2021-01-01 → 2021-12-31	Cons.	Income before income taxes
Profit before tax	¥1.8bn	2020-01-01 → 2020-12-31	Cons.	Income before income taxes
Net income (owners)	¥299m	2021-01-01 → 2021-12-31	Cons.	Profit loss attributable to owners of parent
Net income (owners)	¥1.1bn	2020-01-01 → 2020-12-31	Cons.	Profit loss attributable to owners of parent
Net income (owners)	¥1.1bn	2019-01-01 → 2019-12-31^d	Cons.	Profit loss attributable to owners of parent (5-year summary)
Net income (owners)	¥469m	2018-01-01 → 2018-12-31^d	Cons.	Profit loss attributable to owners of parent (5-year summary)
Net income (owners)	¥1.3bn	2017-01-01 → 2017-12-31^d	Cons.	Profit loss attributable to owners of parent (5-year summary)
Net income	¥261m	2021-01-01 → 2021-12-31	Cons.	Profit loss
Net income	¥1.2bn	2020-01-01 → 2020-12-31	Cons.	Profit loss
Total assets	¥52.3bn	at 2021-12-31	Cons.	Assets
Total assets	¥51.7bn	at 2020-12-31	Cons.	Assets
Total assets	¥52.6bn	at 2019-12-31^d	Cons.	Total assets (5-year summary)
Total assets	¥53.3bn	at 2018-12-31^d	Cons.	Total assets (5-year summary)
Total assets	¥54.5bn	at 2017-12-31^d	Cons.	Total assets (5-year summary)
Total liabilities	¥30.2bn	at 2021-12-31	Cons.	Liabilities
Total liabilities	¥29.6bn	at 2020-12-31	Cons.	Liabilities
Net assets / equity	¥22.0bn	at 2021-12-31	Cons.	Net assets
Net assets / equity	¥22.1bn	at 2020-12-31	Cons.	Net assets
Net assets / equity	¥21.8bn	at 2019-12-31^d	Cons.	Net assets
Net assets / equity	¥21.2bn	at 2018-12-31^d	Cons.	Net assets (5-year summary)
Net assets / equity	¥21.3bn	at 2017-12-31^d	Cons.	Net assets (5-year summary)
Cash and deposits	¥990m	at 2021-12-31	Cons.	Cash and deposits
Cash and deposits	¥915m	at 2020-12-31	Cons.	Cash and deposits
Cash & equivalents	¥986m	at 2021-12-31	Cons.	Cash and cash equivalents
Cash & equivalents	¥910m	at 2020-12-31	Cons.	Cash and cash equivalents
Cash & equivalents	¥1.2bn	at 2019-12-31^d	Cons.	Cash and cash equivalents
Cash & equivalents	¥1.2bn	at 2018-12-31^d	Cons.	Cash and cash equivalents (5-year summary)
Cash & equivalents	¥1.3bn	at 2017-12-31^d	Cons.	Cash and cash equivalents (5-year summary)
Operating cash flow	¥1.6bn	2021-01-01 → 2021-12-31	Cons.	Net cash provided by used in operating activities
Operating cash flow	¥4.8bn	2020-01-01 → 2020-12-31	Cons.	Net cash provided by used in operating activities
Operating cash flow	¥3.9bn	2019-01-01 → 2019-12-31^d	Cons.	Net cash provided by used in operating activities (5-year summary)
Operating cash flow	¥3.7bn	2018-01-01 → 2018-12-31^d	Cons.	Net cash provided by used in operating activities (5-year summary)
Operating cash flow	¥3.1bn	2017-01-01 → 2017-12-31^d	Cons.	Net cash provided by used in operating activities (5-year summary)
Investing cash flow	−¥2.9bn	2021-01-01 → 2021-12-31	Cons.	Net cash provided by used in investment activities
Investing cash flow	−¥3.5bn	2020-01-01 → 2020-12-31	Cons.	Net cash provided by used in investment activities
Investing cash flow	−¥2.3bn	2019-01-01 → 2019-12-31^d	Cons.	Net cash provided by used in investing activities (5-year summary)
Investing cash flow	−¥3.0bn	2018-01-01 → 2018-12-31^d	Cons.	Net cash provided by used in investing activities (5-year summary)
Investing cash flow	−¥2.0bn	2017-01-01 → 2017-12-31^d	Cons.	Net cash provided by used in investing activities (5-year summary)
Financing cash flow	¥1.4bn	2021-01-01 → 2021-12-31	Cons.	Net cash provided by used in financing activities
Financing cash flow	−¥1.5bn	2020-01-01 → 2020-12-31	Cons.	Net cash provided by used in financing activities
Financing cash flow	−¥1.7bn	2019-01-01 → 2019-12-31^d	Cons.	Net cash provided by used in financing activities (5-year summary)
Financing cash flow	−¥828m	2018-01-01 → 2018-12-31^d	Cons.	Net cash provided by used in financing activities (5-year summary)
Financing cash flow	−¥1.7bn	2017-01-01 → 2017-12-31^d	Cons.	Net cash provided by used in financing activities (5-year summary)
EPS (basic)	¥5.03	2021-01-01 → 2021-12-31	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥19.26	2020-01-01 → 2020-12-31	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥18.28	2019-01-01 → 2019-12-31^d	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥7.77	2018-01-01 → 2018-12-31^d	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥20.82	2017-01-01 → 2017-12-31^d	Cons.	Basic earnings loss per share (5-year summary)
Net assets per share	¥336.73	at 2021-12-31	Cons.	Net assets per share (5-year summary)
Net assets per share	¥336.41	at 2020-12-31	Cons.	Net assets per share (5-year summary)
Net assets per share	¥328.38	at 2019-12-31^d	Cons.	Net assets per share (5-year summary)
Net assets per share	¥315.65	at 2018-12-31^d	Cons.	Net assets per share (5-year summary)
Net assets per share	¥317.39	at 2017-12-31^d	Cons.	Net assets per share (5-year summary)
Equity ratio	38.3%	at 2021-12-31	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	38.7%	at 2020-12-31	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	37.6%	at 2019-12-31^d	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	35.8%	at 2018-12-31^d	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	35.2%	at 2017-12-31^d	Cons.	Equity to asset ratio (5-year summary)
ROE	1.5%	2021-01-01 → 2021-12-31	Cons.	Rate of return on equity (5-year summary)
ROE	5.8%	2020-01-01 → 2020-12-31	Cons.	Rate of return on equity (5-year summary)
ROE	5.7%	2019-01-01 → 2019-12-31^d	Cons.	Rate of return on equity (5-year summary)
ROE	2.5%	2018-01-01 → 2018-12-31^d	Cons.	Rate of return on equity (5-year summary)
ROE	6.7%	2017-01-01 → 2017-12-31^d	Cons.	Rate of return on equity (5-year summary)
Employees	879	at 2021-12-31	Cons.	Number of employees
Employees	908	at 2020-12-31	Cons.	Number of employees
Employees	906	at 2019-12-31^d	Cons.	Number of employees
Employees	947	at 2018-12-31^d	Cons.	Number of employees
Employees	955	at 2017-12-31^d	Cons.	Number of employees
Revenue	¥2.5bn	2021-01-01 → 2021-12-31	Standalone	Net sales
Revenue	¥2.5bn	2020-01-01 → 2020-12-31	Standalone	Net sales
Revenue	¥2.5bn	2019-01-01 → 2019-12-31^d	Standalone	Net sales (5-year summary)
Revenue	¥2.6bn	2018-01-01 → 2018-12-31^d	Standalone	Net sales (5-year summary)
Revenue	¥2.5bn	2017-01-01 → 2017-12-31^d	Standalone	Net sales (5-year summary)
Operating income	¥1.2bn	2021-01-01 → 2021-12-31	Standalone	Operating income
Operating income	¥1.1bn	2020-01-01 → 2020-12-31	Standalone	Operating income
Ordinary income	¥1.2bn	2021-01-01 → 2021-12-31	Standalone	Ordinary income
Ordinary income	¥1.0bn	2020-01-01 → 2020-12-31	Standalone	Ordinary income
Ordinary income	¥853m	2019-01-01 → 2019-12-31^d	Standalone	Ordinary income loss (5-year summary)
Ordinary income	¥625m	2018-01-01 → 2018-12-31^d	Standalone	Ordinary income loss (5-year summary)
Ordinary income	¥166m	2017-01-01 → 2017-12-31^d	Standalone	Ordinary income loss (5-year summary)
Profit before tax	¥983m	2021-01-01 → 2021-12-31	Standalone	Income before income taxes
Profit before tax	¥717m	2020-01-01 → 2020-12-31	Standalone	Income before income taxes
Net income	¥839m	2021-01-01 → 2021-12-31	Standalone	Profit loss
Net income	¥716m	2020-01-01 → 2020-12-31	Standalone	Profit loss
Net income	¥979m	2019-01-01 → 2019-12-31^d	Standalone	Net income loss (5-year summary)
Net income	¥87m	2018-01-01 → 2018-12-31^d	Standalone	Net income loss (5-year summary)
Net income	¥85m	2017-01-01 → 2017-12-31^d	Standalone	Net income loss (5-year summary)
Total assets	¥34.8bn	at 2021-12-31	Standalone	Assets
Total assets	¥33.4bn	at 2020-12-31	Standalone	Assets
Total assets	¥33.2bn	at 2019-12-31^d	Standalone	Total assets (5-year summary)
Total assets	¥33.3bn	at 2018-12-31^d	Standalone	Total assets (5-year summary)
Total assets	¥33.9bn	at 2017-12-31^d	Standalone	Total assets (5-year summary)
Total liabilities	¥18.1bn	at 2021-12-31	Standalone	Liabilities
Total liabilities	¥17.3bn	at 2020-12-31	Standalone	Liabilities
Net assets / equity	¥16.6bn	at 2021-12-31	Standalone	Net assets
Net assets / equity	¥16.2bn	at 2020-12-31	Standalone	Net assets
Net assets / equity	¥16.3bn	at 2019-12-31^d	Standalone	Net assets
Net assets / equity	¥15.9bn	at 2018-12-31^d	Standalone	Net assets (5-year summary)
Net assets / equity	¥16.3bn	at 2017-12-31^d	Standalone	Net assets (5-year summary)
Cash and deposits	¥140m	at 2021-12-31	Standalone	Cash and deposits
Cash and deposits	¥120m	at 2020-12-31	Standalone	Cash and deposits
EPS (basic)	¥14.13	2021-01-01 → 2021-12-31	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥12.03	2020-01-01 → 2020-12-31	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥16.21	2019-01-01 → 2019-12-31^d	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥1.45	2018-01-01 → 2018-12-31^d	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥1.42	2017-01-01 → 2017-12-31^d	Standalone	Basic earnings loss per share (5-year summary)
Dividend per share	¥7	2021-01-01 → 2021-12-31	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥7	2020-01-01 → 2020-12-31	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥7	2019-01-01 → 2019-12-31^d	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥7	2018-01-01 → 2018-12-31^d	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥7	2017-01-01 → 2017-12-31^d	Standalone	Dividend paid per share (5-year summary)
Net assets per share	¥279.87	at 2021-12-31	Standalone	Net assets per share (5-year summary)
Net assets per share	¥272.03	at 2020-12-31	Standalone	Net assets per share (5-year summary)
Net assets per share	¥270.67	at 2019-12-31^d	Standalone	Net assets per share (5-year summary)
Net assets per share	¥262.74	at 2018-12-31^d	Standalone	Net assets per share (5-year summary)
Net assets per share	¥270.12	at 2017-12-31^d	Standalone	Net assets per share (5-year summary)
Equity ratio	47.8%	at 2021-12-31	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	48.4%	at 2020-12-31	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	49.1%	at 2019-12-31^d	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	47.7%	at 2018-12-31^d	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	48.1%	at 2017-12-31^d	Standalone	Equity to asset ratio (5-year summary)
ROE	5.1%	2021-01-01 → 2021-12-31	Standalone	Rate of return on equity (5-year summary)
ROE	4.4%	2020-01-01 → 2020-12-31	Standalone	Rate of return on equity (5-year summary)
ROE	6.1%	2019-01-01 → 2019-12-31^d	Standalone	Rate of return on equity (5-year summary)
ROE	0.5%	2018-01-01 → 2018-12-31^d	Standalone	Rate of return on equity (5-year summary)
ROE	0.5%	2017-01-01 → 2017-12-31^d	Standalone	Rate of return on equity (5-year summary)
Shares issued	65,586,196	at 2021-12-31	Standalone	Total number of issued shares (5-year summary)
Shares issued	65,586,196	at 2020-12-31	Standalone	Total number of issued shares (5-year summary)
Shares issued	65,586,196	at 2019-12-31^d	Standalone	Total number of issued shares (5-year summary)
Shares issued	65,586,196	at 2018-12-31^d	Standalone	Total number of issued shares (5-year summary)
Shares issued	65,586,196	at 2017-12-31^d	Standalone	Total number of issued shares (5-year summary)
Employees	37	at 2021-12-31	Standalone	Number of employees
Employees	44	at 2020-12-31	Standalone	Number of employees
Employees	46	at 2019-12-31^d	Standalone	Number of employees
Employees	51	at 2018-12-31^d	Standalone	Number of employees
Employees	49	at 2017-12-31^d	Standalone	Number of employees

Periods use the dates stated in the filing. ^d = earlier-year period dated by calendar; ^v = that date confirmed by the company's own earlier filing.

Segments · 88

Segment	Item	Period	Value
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	depreciation	2021-01-01 → 2021-12-31	¥0
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	revenue	2021-01-01 → 2021-12-31	¥71m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	revenue external	2021-01-01 → 2021-12-31	¥71m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	segment assets	at 2021-12-31	¥47m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	segment profit	2021-01-01 → 2021-12-31	¥14m
Reconciling Itemsreconciling	capex	2021-01-01 → 2021-12-31	¥1.3bn
Reconciling Itemsreconciling	depreciation	2021-01-01 → 2021-12-31	¥148m
Reconciling Itemsreconciling	revenue	2021-01-01 → 2021-12-31	−¥12m
Reconciling Itemsreconciling	revenue intersegment	2021-01-01 → 2021-12-31	−¥12m
Reconciling Itemsreconciling	segment assets	at 2021-12-31	¥4.5bn
Enzymatic Medicinereportable segment	capex	2021-01-01 → 2021-12-31	¥85m
Enzymatic Medicinereportable segment	depreciation	2021-01-01 → 2021-12-31	¥243m
Enzymatic Medicinereportable segment	employees	at 2021-12-31	113 pure
Enzymatic Medicinereportable segment	revenue	2021-01-01 → 2021-12-31	¥3.3bn
Enzymatic Medicinereportable segment	revenue external	2021-01-01 → 2021-12-31	¥3.3bn
Enzymatic Medicinereportable segment	segment assets	at 2021-12-31	¥3.5bn
Enzymatic Medicinereportable segment	segment profit	2021-01-01 → 2021-12-31	¥566m
Liquorreportable segment	capex	2021-01-01 → 2021-12-31	¥593m
Liquorreportable segment	depreciation	2021-01-01 → 2021-12-31	¥1.2bn
Liquorreportable segment	employees	at 2021-12-31	699 pure
Liquorreportable segment	revenue	2021-01-01 → 2021-12-31	¥71.1bn
Liquorreportable segment	revenue external	2021-01-01 → 2021-12-31	¥71.1bn
Liquorreportable segment	revenue intersegment	2021-01-01 → 2021-12-31	¥12m
Liquorreportable segment	segment assets	at 2021-12-31	¥39.0bn
Liquorreportable segment	segment profit	2021-01-01 → 2021-12-31	¥499m
Real Estatereportable segment	capex	2021-01-01 → 2021-12-31	¥312m
Real Estatereportable segment	depreciation	2021-01-01 → 2021-12-31	¥46m
Real Estatereportable segment	employees	at 2021-12-31	1 pure
Real Estatereportable segment	revenue	2021-01-01 → 2021-12-31	¥360m
Real Estatereportable segment	revenue external	2021-01-01 → 2021-12-31	¥360m
Real Estatereportable segment	segment assets	at 2021-12-31	¥2.5bn
Real Estatereportable segment	segment profit	2021-01-01 → 2021-12-31	¥185m
Starch For Processingreportable segment	capex	2021-01-01 → 2021-12-31	¥20m
Starch For Processingreportable segment	depreciation	2021-01-01 → 2021-12-31	¥56m
Starch For Processingreportable segment	employees	at 2021-12-31	29 pure
Starch For Processingreportable segment	revenue	2021-01-01 → 2021-12-31	¥3.8bn
Starch For Processingreportable segment	revenue external	2021-01-01 → 2021-12-31	¥3.8bn
Starch For Processingreportable segment	segment assets	at 2021-12-31	¥2.7bn
Starch For Processingreportable segment	segment profit	2021-01-01 → 2021-12-31	−¥59m
—segment total	capex	2021-01-01 → 2021-12-31	¥1.0bn
—segment total	depreciation	2021-01-01 → 2021-12-31	¥1.6bn
—segment total	revenue	2021-01-01 → 2021-12-31	¥78.6bn
—segment total	revenue external	2021-01-01 → 2021-12-31	¥78.5bn
—segment total	revenue intersegment	2021-01-01 → 2021-12-31	¥12m
—segment total	segment assets	at 2021-12-31	¥47.7bn
—segment total	segment profit	2021-01-01 → 2021-12-31	¥1.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	depreciation	2020-01-01 → 2020-12-31	¥0
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	revenue	2020-01-01 → 2020-12-31	¥72m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	revenue external	2020-01-01 → 2020-12-31	¥72m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	segment assets	at 2020-12-31	¥58m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	segment profit	2020-01-01 → 2020-12-31	¥13m
Reconciling Itemsreconciling	capex	2020-01-01 → 2020-12-31	¥558m
Reconciling Itemsreconciling	depreciation	2020-01-01 → 2020-12-31	¥220m
Reconciling Itemsreconciling	revenue	2020-01-01 → 2020-12-31	−¥9m
Reconciling Itemsreconciling	revenue intersegment	2020-01-01 → 2020-12-31	−¥9m
Reconciling Itemsreconciling	segment assets	at 2020-12-31	¥3.7bn
Enzymatic Medicinereportable segment	capex	2020-01-01 → 2020-12-31	¥141m
Enzymatic Medicinereportable segment	depreciation	2020-01-01 → 2020-12-31	¥246m
Enzymatic Medicinereportable segment	revenue	2020-01-01 → 2020-12-31	¥3.3bn
Enzymatic Medicinereportable segment	revenue external	2020-01-01 → 2020-12-31	¥3.3bn
Enzymatic Medicinereportable segment	segment assets	at 2020-12-31	¥3.8bn
Enzymatic Medicinereportable segment	segment profit	2020-01-01 → 2020-12-31	¥591m
Liquorreportable segment	capex	2020-01-01 → 2020-12-31	¥937m
Liquorreportable segment	depreciation	2020-01-01 → 2020-12-31	¥1.2bn
Liquorreportable segment	revenue	2020-01-01 → 2020-12-31	¥70.4bn
Liquorreportable segment	revenue external	2020-01-01 → 2020-12-31	¥70.4bn
Liquorreportable segment	revenue intersegment	2020-01-01 → 2020-12-31	¥9m
Liquorreportable segment	segment assets	at 2020-12-31	¥40.2bn
Liquorreportable segment	segment profit	2020-01-01 → 2020-12-31	¥1.3bn
Real Estatereportable segment	capex	2020-01-01 → 2020-12-31	¥8m
Real Estatereportable segment	depreciation	2020-01-01 → 2020-12-31	¥34m
Real Estatereportable segment	revenue	2020-01-01 → 2020-12-31	¥351m
Real Estatereportable segment	revenue external	2020-01-01 → 2020-12-31	¥351m
Real Estatereportable segment	segment assets	at 2020-12-31	¥1.7bn
Real Estatereportable segment	segment profit	2020-01-01 → 2020-12-31	¥186m
Starch For Processingreportable segment	capex	2020-01-01 → 2020-12-31	¥61m
Starch For Processingreportable segment	depreciation	2020-01-01 → 2020-12-31	¥62m
Starch For Processingreportable segment	revenue	2020-01-01 → 2020-12-31	¥3.6bn
Starch For Processingreportable segment	revenue external	2020-01-01 → 2020-12-31	¥3.6bn
Starch For Processingreportable segment	segment assets	at 2020-12-31	¥2.2bn
Starch For Processingreportable segment	segment profit	2020-01-01 → 2020-12-31	¥148m
—segment total	capex	2020-01-01 → 2020-12-31	¥1.1bn
—segment total	depreciation	2020-01-01 → 2020-12-31	¥1.5bn
—segment total	revenue	2020-01-01 → 2020-12-31	¥77.6bn
—segment total	revenue external	2020-01-01 → 2020-12-31	¥77.6bn
—segment total	revenue intersegment	2020-01-01 → 2020-12-31	¥9m
—segment total	segment assets	at 2020-12-31	¥47.9bn
—segment total	segment profit	2020-01-01 → 2020-12-31	¥2.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,622

Item	Context	Value	Unit
Total return on share price index	Prior2YearInstant_NonConsolidatedMember	1.213
Total return on share price index	Prior1YearInstant_NonConsolidatedMember	1.303
Total return on share price index	CurrentYearInstant_NonConsolidatedMember	1.469
Number of employees	CurrentYearInstant_jpcrp030000-asr_E00397-000LiquorReportableSegmentsMember	699
Average number of temporary workers	CurrentYearInstant_jpcrp030000-asr_E00397-000LiquorReportableSegmentsMember	304
Number of employees	CurrentYearInstant_jpcrp030000-asr_E00397-000StarchForProcessingReportableSegmentsMember	29
Average number of temporary workers	CurrentYearInstant_jpcrp030000-asr_E00397-000StarchForProcessingReportableSegmentsMember	1
Number of employees	CurrentYearInstant_jpcrp030000-asr_E00397-000EnzymaticMedicineReportableSegmentsMember	113
Average number of temporary workers	CurrentYearInstant_jpcrp030000-asr_E00397-000EnzymaticMedicineReportableSegmentsMember	11
Number of employees	CurrentYearInstant_jpcrp030000-asr_E00397-000RealEstateReportableSegmentsMember	1
Average number of temporary workers	CurrentYearInstant_jpcrp030000-asr_E00397-000RealEstateReportableSegmentsMember	－
Number of employees	CurrentYearInstant_CorporateSharedMember	37
Average number of temporary workers	CurrentYearInstant_CorporateSharedMember	8
Number of employees	CurrentYearInstant	879
Average number of temporary workers	CurrentYearInstant	324
Number of employees	CurrentYearInstant_NonConsolidatedMember	37
Average number of temporary workers	CurrentYearInstant_NonConsolidatedMember	8
Average age years information about reporting company information about employees	CurrentYearInstant_NonConsolidatedMember	49
Average age months information about reporting company information about employees	CurrentYearInstant_NonConsolidatedMember	1
Average length of service years information about reporting company information about employees	CurrentYearInstant_NonConsolidatedMember	24
Average length of service months information about reporting company information about employees	CurrentYearInstant_NonConsolidatedMember	1
Average annual salary information about reporting company information about employees	CurrentYearInstant_NonConsolidatedMember	7477000	JPY
Number of employees	CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember	37
Average number of temporary workers	CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember	8
Number of employees	CurrentYearInstant_NonConsolidatedMember	37
Average number of temporary workers	CurrentYearInstant_NonConsolidatedMember	8
Research and development expenses research and development activities	CurrentYearDuration	538000000	JPY
Research and development expenses research and development activities	CurrentYearDuration_jpcrp030000-asr_E00397-000LiquorReportableSegmentsMember	119000000	JPY
Research and development expenses research and development activities	CurrentYearDuration_jpcrp030000-asr_E00397-000EnzymaticMedicineReportableSegmentsMember	418000000	JPY
Capital expenditures overview of capital expenditures etc	CurrentYearDuration	2190000000	JPY
Capital expenditures overview of capital expenditures etc	CurrentYearDuration_jpcrp030000-asr_E00397-000LiquorReportableSegmentsMember	586000000	JPY
Capital expenditures overview of capital expenditures etc	CurrentYearDuration_jpcrp030000-asr_E00397-000StarchForProcessingReportableSegmentsMember	20000000	JPY
Capital expenditures overview of capital expenditures etc	CurrentYearDuration_jpcrp030000-asr_E00397-000EnzymaticMedicineReportableSegmentsMember	85000000	JPY
Capital expenditures overview of capital expenditures etc	CurrentYearDuration_jpcrp030000-asr_E00397-000RealEstateReportableSegmentsMember	312000000	JPY
Capital expenditures overview of capital expenditures etc	CurrentYearDuration_CorporateSharedMember	1186000000	JPY
Capital expenditures overview of capital expenditures etc	CurrentYearDuration_ReportableSegmentsMember	2190000000	JPY
Number of issued shares as of fiscal year end issued shares total number of shares etc	FilingDateInstant_OrdinaryShareMember	65586196
Number of issued shares as of filing date issued shares total number of shares etc	FilingDateInstant_OrdinaryShareMember	65586196
Number of issued shares as of fiscal year end issued shares total number of shares etc	FilingDateInstant	65586196
Number of issued shares as of filing date issued shares total number of shares etc	FilingDateInstant	65586196
Number of shares constituting one unit	CurrentYearInstant_OrdinaryShareMember	100
Number of shareholders national and local governments	CurrentYearInstant_OrdinaryShareMember	－
Number of shareholders financial institutions	CurrentYearInstant_OrdinaryShareMember	25
Number of shareholders financial service providers	CurrentYearInstant_OrdinaryShareMember	27
Number of shareholders other corporations	CurrentYearInstant_OrdinaryShareMember	150
Number of shareholders foreign investors other than individuals	CurrentYearInstant_OrdinaryShareMember	67
Number of shareholders foreign individual investors	CurrentYearInstant_OrdinaryShareMember	9
Number of shareholders individuals and others	CurrentYearInstant_OrdinaryShareMember	10519
Number of shareholders total	CurrentYearInstant_OrdinaryShareMember	10797
Number of shares held number of units national and local governments	CurrentYearInstant_OrdinaryShareMember	－

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed

balance sheet identity	consolidated 2020-12-31	pass
balance sheet identity	consolidated 2021-12-31	pass
balance sheet identity	non_consolidated 2020-12-31	pass
balance sheet identity	non_consolidated 2021-12-31	pass rounding
dei present		pass
period resolution		pass
statement vs summary · net assets	consolidated 2019-12-31	pass
statement vs summary · net assets	consolidated 2020-12-31	pass
statement vs summary · net assets	consolidated 2021-12-31	pass
statement vs summary · net assets	non_consolidated 2019-12-31	pass
statement vs summary · net assets	non_consolidated 2020-12-31	pass
statement vs summary · net assets	non_consolidated 2021-12-31	pass
statement vs summary · net income attributable to parent	consolidated 2020-01-01/2020-12-31	pass
statement vs summary · net income attributable to parent	consolidated 2021-01-01/2021-12-31	pass
statement vs summary · operating cash flow	consolidated 2020-01-01/2020-12-31	pass
statement vs summary · operating cash flow	consolidated 2021-01-01/2021-12-31	pass
statement vs summary · revenue	consolidated 2020-01-01/2020-12-31	pass
statement vs summary · revenue	consolidated 2021-01-01/2021-12-31	pass
statement vs summary · revenue	non_consolidated 2020-01-01/2020-12-31	pass
statement vs summary · revenue	non_consolidated 2021-01-01/2021-12-31	pass
statement vs summary · total assets	consolidated 2020-12-31	pass
statement vs summary · total assets	consolidated 2021-12-31	pass
statement vs summary · total assets	non_consolidated 2020-12-31	pass
statement vs summary · total assets	non_consolidated 2021-12-31	pass